PRELUDE CAPITAL MANAGEMENT, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$11,000
+22.2%
245
+31.7%
0.00%
Q2 2020$9,000
-10.0%
1860.0%0.00%
-100.0%
Q1 2020$10,000
-88.2%
186
-86.5%
0.00%
-66.7%
Q4 2019$85,000
+750.0%
1,380
+1089.7%
0.00%
+200.0%
Q3 2018$10,000
-52.4%
116
-34.8%
0.00%0.0%
Q2 2018$21,000
+133.3%
178
+21.9%
0.00%0.0%
Q4 2017$9,000
-65.4%
146
-73.8%
0.00%
-50.0%
Q3 2017$26,000
+4.0%
558
-20.7%
0.00%0.0%
Q2 2017$25,000
-70.2%
704
-74.3%
0.00%
-75.0%
Q1 2017$84,000
-58.2%
2,735
-54.4%
0.01%
-66.7%
Q4 2016$201,000
-38.5%
6,002
-51.1%
0.02%
-29.4%
Q3 2016$327,000
+118.0%
12,280
+79.9%
0.03%
+61.9%
Q2 2016$150,000
+200.0%
6,825
+301.5%
0.02%
+200.0%
Q1 2016$50,000
-85.0%
1,700
-77.0%
0.01%
-85.1%
Q2 2015$333,000
+674.4%
7,400
+428.6%
0.05%
+683.3%
Q1 2015$43,000
-75.8%
1,400
-60.0%
0.01%
-76.9%
Q4 2014$178,000
+6.6%
3,500
-17.1%
0.03%
+8.3%
Q3 2014$167,0004,2200.02%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders